On 27 November 2018 the Court of Appeal of The Hague in the Netherlands reversed the first instance court’s decision, confirming the validity of AstraZeneca’s patents on their breast cancer drug Faslodex® and reinstating the earlier injunction against Sandoz in PI proceedings. With this decision the Court of Appeal confirms…
The Brussels office of HOYNG ROKH MONEGIER is pleased to be one of the founding members of the Legal Diversity & Inclusion Alliance (LDIA), a collective effort by several law firms in Belgium.